Commerce Bank acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 1,238,538 shares of the company’s stock, valued at approximately $159,152,000. Merck KGaA accounts for 0.7% of Commerce Bank’s holdings, making the stock its 26th biggest holding. Commerce Bank owned 0.96% of Merck KGaA as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also made changes to their positions in MKGAF. Frazier Financial Advisors LLC purchased a new stake in shares of Merck KGaA during the second quarter worth approximately $25,000. Rakuten Securities Inc. purchased a new position in Merck KGaA in the second quarter worth approximately $27,000. Bard Associates Inc. acquired a new position in Merck KGaA during the 2nd quarter worth approximately $60,000. Kilter Group LLC acquired a new position in Merck KGaA during the 2nd quarter worth approximately $62,000. Finally, Addison Advisors LLC purchased a new stake in shares of Merck KGaA in the 2nd quarter valued at approximately $90,000. 0.10% of the stock is owned by institutional investors and hedge funds.
Merck KGaA Price Performance
Shares of MKGAF opened at $163.21 on Friday. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The firm’s fifty day simple moving average is $162.62 and its 200-day simple moving average is $148.46. The firm has a market capitalization of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
